229 related articles for article (PubMed ID: 17222580)
1. Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia.
Farrer MJ; Stone JT; Lin CH; Dächsel JC; Hulihan MM; Haugarvoll K; Ross OA; Wu RM
Parkinsonism Relat Disord; 2007 Mar; 13(2):89-92. PubMed ID: 17222580
[TBL] [Abstract][Full Text] [Related]
2. The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population.
Kim JM; Lee JY; Kim HJ; Kim JS; Shin ES; Cho JH; Park SS; Jeon BS
Parkinsonism Relat Disord; 2010 Feb; 16(2):85-8. PubMed ID: 19854095
[TBL] [Abstract][Full Text] [Related]
3. LRRK2 G2385R and R1628P mutations are associated with an increased risk of Parkinson's disease in the Malaysian population.
Gopalai AA; Lim SY; Chua JY; Tey S; Lim TT; Mohamed Ibrahim N; Tan AH; Eow GB; Abdul Aziz Z; Puvanarajah SD; Viswanathan S; Looi I; Lim SK; Tan LP; Chong YB; Tan CT; Zhao Y; Tan EK; Ahmad-Annuar A
Biomed Res Int; 2014; 2014():867321. PubMed ID: 25243190
[TBL] [Abstract][Full Text] [Related]
4. LRRK2 G2385R variant carriers of female Parkinson's disease are more susceptible to motor fluctuation.
Gao C; Pang H; Luo XG; Ren Y; Shang H; He ZY
J Neurol; 2013 Nov; 260(11):2884-9. PubMed ID: 24046064
[TBL] [Abstract][Full Text] [Related]
5. LRRK2 Gly2385Arg variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China.
An XK; Peng R; Li T; Burgunder JM; Wu Y; Chen WJ; Zhang JH; Wang YC; Xu YM; Gou YR; Yuan GG; Zhang ZJ
Eur J Neurol; 2008 Mar; 15(3):301-5. PubMed ID: 18201193
[TBL] [Abstract][Full Text] [Related]
6. MAPT IVS1+124 C>G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals.
Dan X; Wang C; Ma J; Feng X; Wang T; Zheng Z; Chan P
Neurobiol Aging; 2014 Jul; 35(7):1780.e7-1780.e10. PubMed ID: 24559644
[TBL] [Abstract][Full Text] [Related]
7. LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease.
Zabetian CP; Yamamoto M; Lopez AN; Ujike H; Mata IF; Izumi Y; Kaji R; Maruyama H; Morino H; Oda M; Hutter CM; Edwards KL; Schellenberg GD; Tsuang DW; Yearout D; Larson EB; Kawakami H
Mov Disord; 2009 May; 24(7):1034-41. PubMed ID: 19343804
[TBL] [Abstract][Full Text] [Related]
8. The association between the LRRK2 G2385R variant and the risk of Parkinson's disease: a meta-analysis based on 23 case-control studies.
Xie CL; Pan JL; Wang WW; Zhang Y; Zhang SF; Gan J; Liu ZG
Neurol Sci; 2014 Oct; 35(10):1495-504. PubMed ID: 25027012
[TBL] [Abstract][Full Text] [Related]
9. LRRK2 Gly2385Arg mutation and clinical features in a Chinese population with early-onset Parkinson's disease compared to late-onset patients.
Chan DK; Ng PW; Mok V; Yeung J; Fang ZM; Clarke R; Leung E; Wong L
J Neural Transm (Vienna); 2008 Sep; 115(9):1275-7. PubMed ID: 18523722
[TBL] [Abstract][Full Text] [Related]
10. Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease.
Liu J; Zhou Y; Wang C; Wang T; Zheng Z; Chan P
Parkinsonism Relat Disord; 2012 Feb; 18(2):140-3. PubMed ID: 21924942
[TBL] [Abstract][Full Text] [Related]
11. The LRRK2 gene is mutated in a Chinese autosomal-dominant Parkinson's disease family.
Guo R; Hu X; Chen Q; Zhang Y; Zhang Y; Sun Y; Hu G
Genet Test Mol Biomarkers; 2013 Feb; 17(2):131-4. PubMed ID: 23268655
[TBL] [Abstract][Full Text] [Related]
12. LRRK2 G2385R and LRRK2 R1628P increase risk of Parkinson's disease in a Han Chinese population from Southern Mainland China.
Fu X; Zheng Y; Hong H; He Y; Zhou S; Guo C; Liu Y; Xian W; Zeng J; Li J; Liu Z; Chen L; Pei Z
Parkinsonism Relat Disord; 2013 Mar; 19(3):397-8. PubMed ID: 22981185
[No Abstract] [Full Text] [Related]
13. LRRK2 mutations in Basque patients with Parkinson's disease.
Zarranz JJ; Gómez-Esteban JC
Lancet Neurol; 2008 Oct; 7(10):866-7; author reply 867. PubMed ID: 18848304
[No Abstract] [Full Text] [Related]
14. Uniting Chinese across Asia: the LRRK2 Gly2385Arg risk variant.
Tan EK; Schapira AH
Eur J Neurol; 2008 Mar; 15(3):203-4. PubMed ID: 18290841
[No Abstract] [Full Text] [Related]
15. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.
Ross OA; Soto-Ortolaza AI; Heckman MG; Aasly JO; Abahuni N; Annesi G; Bacon JA; Bardien S; Bozi M; Brice A; Brighina L; Van Broeckhoven C; Carr J; Chartier-Harlin MC; Dardiotis E; Dickson DW; Diehl NN; Elbaz A; Ferrarese C; Ferraris A; Fiske B; Gibson JM; Gibson R; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lesage S; Lin CH; Lynch T; Maraganore DM; Mellick GD; Mutez E; Nilsson C; Opala G; Park SS; Puschmann A; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Theuns J; Tomiyama H; Uitti RJ; Valente EM; van de Loo S; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Farrer MJ;
Lancet Neurol; 2011 Oct; 10(10):898-908. PubMed ID: 21885347
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants ofLRRK2 in Taiwanese Parkinson's disease.
Wu YR; Chang KH; Chang WT; Hsiao YC; Hsu HC; Jiang PR; Chen YC; Chao CY; Chang YC; Lee BH; Hu FJ; Chen WL; Lee-Chen GJ; Chen CM
PLoS One; 2013; 8(12):e82001. PubMed ID: 24339985
[TBL] [Abstract][Full Text] [Related]
17. LRRK2 G2019S founder haplotype in the Chinese population.
Tan EK; Skipper L; Tan L; Liu JJ
Mov Disord; 2007 Jan; 22(1):105-7. PubMed ID: 17083102
[TBL] [Abstract][Full Text] [Related]
18. Non-motor symptoms in Chinese Parkinson's disease patients with and without LRRK2 G2385R and R1628P variants.
Li DW; Gu Z; Wang C; Ma J; Tang BS; Chen SD; Chan P
J Neural Transm (Vienna); 2015 May; 122(5):661-7. PubMed ID: 25062988
[TBL] [Abstract][Full Text] [Related]
19. Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease.
Monfrini E; Di Fonzo A
Adv Neurobiol; 2017; 14():3-30. PubMed ID: 28353276
[TBL] [Abstract][Full Text] [Related]
20. LRRK2 haplotype-sharing analysis in Parkinson's disease reveals a novel p.S1761R mutation.
Lorenzo-Betancor O; Samaranch L; Ezquerra M; Tolosa E; Lorenzo E; Irigoyen J; Gaig C; Pastor MA; Soto-Ortolaza AI; Ross OA; Rodríguez-Oroz MC; Valldeoriola F; Martí MJ; Luquin MR; Perez-Tur J; Burguera JA; Obeso JA; Pastor P
Mov Disord; 2012 Jan; 27(1):146-51. PubMed ID: 22038903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
